During the past decade, Sacco Eye Group conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 33 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 25 clinical trials were completed. i.e. 104.2% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sacco Eye Group" #1 collaborator was "Visioncare Research Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sacco Eye Group" are "Visual Acuity" (23 trials), "Myopia" (8 trials), "Ocular Physiology" (3 trials), "Hyperopia" (2 trials) and "Juvenile Myopia" (2 trials). Many other conditions were trialed in "Sacco Eye Group" in a lesser frequency.

Most popular intervention types in "Sacco Eye Group" are "Device" (43 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "comfilcon A" (3 trials), "senofilcon C" (3 trials), "CONTROL LENS" (2 trials), "Dailies Total 1® Multifocal Contact Lens" (2 trials) and "Dailies Total 1® Multifocal Contact Lenses" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sacco Eye Group" are 42 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sacco Eye Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Sacco Eye Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sacco Eye Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 42 trials that are defined as “Not Applicable".